Biogen Inc. buy Royal Bank of Canada
Start price
14.02.24
/
50%
€210.80
Target price
14.02.25
€339.39
Performance (%)
-13.61%
Price
11:10
€182.10
Summary
This prediction is currently active. The prediction for Biogen Inc. disappoints with a performance of -13.61%. This prediction currently runs until 14.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Biogen Inc. | -1.914% | -1.914% |
iShares Core DAX® | -1.611% | 3.135% |
iShares Nasdaq 100 | -0.500% | 0.775% |
iShares Nikkei 225® | -1.483% | 4.610% |
iShares S&P 500 | -0.501% | 1.914% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $379.00 to $364.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat